aDepartments of Anesthesia and Critical Care Medicine, Critical Illness and Injury Research Centre, Keenan Research Centre for Biomedical Science, St Michael's Hospital bDepartments of Anesthesia, Physiology and Interdepartmental Division of Critical Care Medicine University of Toronto cDepartment of Critical Care Medicine, Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Canada dDepartment of Health Science, University of Milan-Bicocca eDepartment of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy.
Curr Opin Crit Care. 2017 Feb;23(1):10-17. doi: 10.1097/MCC.0000000000000381.
Timely recognition of acute respiratory distress syndrome (ARDS) may allow for more prompt management and less exacerbation of lung injury. However, the absence of a diagnostic test for ARDS means that the diagnosis of ARDS requires clinician recognition in what is usually a complicated and evolving illness. We review data concerning the extent of recognition of ARDS in the era of the Berlin definition of ARDS.
ARDS continues to be under-recognized - even in the era of the more recent 'Berlin' definition, and significant delay in its recognition is common. Factors contributing to under-recognition may include the complexity of ARDS biology, low specificity of the consensus (diagnostic) criteria, and concerns about reliable interpretation of the chest radiograph. Understandably, 'external' factors are also at play: ICU occupancy and higher patient to clinician ratio impair recognition of ARDS. Timely recognition of ARDS appears important, as it is associated with the use of higher PEEP, prone positioning and neuromuscular blockade which can lower mortality. Computer-aided decision tools seem diagnostically useful, and together with the integration of reliable biomarkers, may further enhance and speed recognition of this syndrome.
Significant numbers of patients with ARDS are still unrecognized by clinicians in the era of the Berlin definition of ARDS, with potentially important consequences for patient management and outcome.
及时识别急性呼吸窘迫综合征(ARDS)可能有助于更及时地管理和减轻肺损伤。然而,由于缺乏 ARDS 的诊断测试,因此 ARDS 的诊断需要临床医生在通常复杂且不断发展的疾病中进行识别。我们回顾了关于在柏林 ARDS 定义时代识别 ARDS 的程度的数据。
即使在最近的“柏林”定义时代,ARDS 仍然未被充分识别,其识别的明显延迟也很常见。导致识别不足的因素可能包括 ARDS 生物学的复杂性、共识(诊断)标准的特异性低,以及对可靠解读胸片的担忧。可以理解的是,“外部”因素也在起作用:ICU 入住率和患者与临床医生的比例较高会影响 ARDS 的识别。及时识别 ARDS 似乎很重要,因为它与使用更高的 PEEP、俯卧位和神经肌肉阻滞剂有关,这些措施可以降低死亡率。计算机辅助决策工具在诊断上似乎很有用,并且与可靠的生物标志物的整合,可能会进一步增强和加速对这种综合征的识别。
在柏林 ARDS 定义时代,仍有大量 ARDS 患者未被临床医生识别,这可能对患者的管理和预后产生重要影响。